Discover Compass Pathways' journey in developing COMP360 psilocybin for treatment-resistant depression, tackling regulatory ...

Kamada continues to expect to generate fiscal year 2025 total revenues in the range of $178 million to $182 million, and adjusted EBITDA in the range of $38 million to $42 million, representing a year ...

On both sides of the pond, in both the U.S. and the UK, 2016 was a pivotal year, which has gone on to define the political ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced a partnership with Qureight, a ...

The 10th overall pick in the 2025 NFL Draft hadn't even been announced when the league dropped this year's schedule release date. Before NFL Commissioner Roger Goodell announced the Chicago Bears ...

Tracking your cycle: no strings (or subscriptions) attached. Since the Galaxy Ring launched last summer, I’ve been wearing it ...

Nearly 7.4 million Social Security beneficiaries will notice a shift in their payment schedule in May due to a quirk in the ...

Apogee's APG808 cut key asthma biomarker FeNO by 53% at 12 weeks with no severe adverse events, showing potential for ...

A zoo has taken inspiration from TV's "Blind Date" to try and get two rare Malagasy fossas to mate as part of an ...

I wanted to be first so she would not be waiting alone. She came a few minutes late. Keven He was on time. I purposely came ...

A UK zoo has taken inspiration from TV’s Blind Date to try and get two rare Malagasy fossas to mate as part of an ...

Cleveland-Cliffs reported a larger than expected Q1 adjusted loss and an 11% Y/Y decline in revenues to $4.63B, and announced ...